2003
DOI: 10.1523/jneurosci.23-11-04785.2003
|View full text |Cite
|
Sign up to set email alerts
|

The Glucocorticoid Receptor as a Potential Target to Reduce Cocaine Abuse

Abstract: Several findings suggest that glucocorticoid hormones are involved in determining the propensity of an individual to develop cocaine abuse. These hormones activate two related transcription factors, the glucocorticoid receptor (GR) and the mineralocorticoid receptor. In this study, we show that the selective inactivation of the GR gene in the brains of mice profoundly flattened the dose-response function for cocaine intravenous self-administration and suppressed sensitization, two experimental procedures consi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
117
1
4

Year Published

2005
2005
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 161 publications
(135 citation statements)
references
References 45 publications
(63 reference statements)
13
117
1
4
Order By: Relevance
“…The anti-GC activity of mifepristone has made it a potential treatment for Cushing's syndrome (Johanssen and Allolio, 2007) and neurological and psychological disorders (DeBattista and Belanoff, 2006;Gallagher and Young, 2006;Gallagher et al, 2005Gallagher et al, , 2008Wulsin et al, 2010;Young, 2006). The drug has also been examined in the self-administration of amphetamine (De Vries et al, 1996), cocaine (Deroche-Gamonet et al, 2003;Fiancette et al, 2010), morphine (Mesripour et al, 2008), and ethanol, where it has been shown to have either no effect or decrease baseline ethanol consumption (Fahlke et al, 1995;Jacquot et al, 2008;Koenig and Olive, 2004;Lowery et al, 2010;O'Callaghan et al, 2005;Roberts et al, 1995;Yang et al, 2008). However, the role of mifepristone in stress-induced reinstatement of ethanol-seeking is not known.…”
Section: Introductionmentioning
confidence: 99%
“…The anti-GC activity of mifepristone has made it a potential treatment for Cushing's syndrome (Johanssen and Allolio, 2007) and neurological and psychological disorders (DeBattista and Belanoff, 2006;Gallagher and Young, 2006;Gallagher et al, 2005Gallagher et al, , 2008Wulsin et al, 2010;Young, 2006). The drug has also been examined in the self-administration of amphetamine (De Vries et al, 1996), cocaine (Deroche-Gamonet et al, 2003;Fiancette et al, 2010), morphine (Mesripour et al, 2008), and ethanol, where it has been shown to have either no effect or decrease baseline ethanol consumption (Fahlke et al, 1995;Jacquot et al, 2008;Koenig and Olive, 2004;Lowery et al, 2010;O'Callaghan et al, 2005;Roberts et al, 1995;Yang et al, 2008). However, the role of mifepristone in stress-induced reinstatement of ethanol-seeking is not known.…”
Section: Introductionmentioning
confidence: 99%
“…We have found that the augmentation of CRF-independent cocaine-induced reinstatement after longaccess SA is also prevented by pre-SA ADX/C (Mantsch et al, 2008b), suggesting that adrenal-dependent adaptations in brain regions that represent a final common pathway for stimuli that induce cocaine seeking may underlie augmented reinstatement. Accordingly, it has been reported that glucocorticoid receptors in dopaminoceptive neurons, likely in the nucleus accumbens, contribute to drug seeking following repeated cocaine delivery, but are not necessary for responses to acute cocaine (Deroche-Gamonet et al, 2003;Ambroggi et al, 2009). …”
Section: Glucocorticoid Regulation Of Crf Actionsmentioning
confidence: 99%
“…Ainsi, chez la souris, il semblerait que l'action sur les récepteurs aux glucocorticoïdes pourrait être un traitement de la dépendance à la cocaïne, notamment par une action sur les hormones du stress, un des facteurs identifiés en clinique comme pouvant induire un « craving », chez les usagers de cocaïne et de crack [13]. Une autre étude, chez le rat, a montré qu'un antagoniste aux cannabinoïdes, le SR141716A, ou rimonabant, était efficace pour réduire l'envie de consommer de la cocaïne [12,28], par un mécanisme agoniste GABAergique indirect.…”
Section: Thérapeutiqueunclassified